Category Archives: "News"

Genentech’s Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide [...]
Dr. Kristen Krysko Wins 2025 Rachel Horne Prize For Women’s Research In Multiple Sclerosis
Dr Kristen Krysko, a Canadian neurologist, researcher and clinician, is the winner of the Rachel Horne Prize for Women’s Research in [...]
CMSC Press Release – Kathleen Costello, CRNP, MSCN Appointed Interim CEO of the CMSC
Kathy Costello The Consortium of Multiple Sclerosis Centers (CMSC) Board of Governors is pleased to announce the appointment of [...]
Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis
Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Designation is [...]
Press Release: New 48-Week Frexalimab Phase 2 Data Support Potential For High Sustained Efficacy In Multiple Sclerosis
New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis Data support frexalimab as a [...]
The Siegel Rare Neuroimmune Association Marks 30 Years of Improving Quality of Life for People With Rare Neuroimmune Disorders
Not-for-profit celebrates past achievements and looks to the future POWELL, Ohio, February 29, 2024 (Newswire.com) - The Siegel Rare [...]
The Language of MS: How Much Does It Matter?
I got an email recently from someone well up the chain of command at a multiple sclerosis (MS) patient advocacy organization. The purpose [...]
Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete Suppression of Brain Lesions
Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete [...]
Is it MS or Something Else? updated guide is published to expedite and uncover the answer
MIDDLETON, WI., July 19, 2023 - An international consortium led by the Americas Committee for Treatment and Research in Multiple [...]
In memoriam: Barry GW Arnason, MD, FAAN
The  MS+ community has lost its 'grandfather.' Barry GW Arnason, MD, FAAN. He is generally regarded as one of (if not, the) founder of [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM